Skip to content

ARRAY BIOPHARMA INC: filings

Every ARRAY BIOPHARMA INC annual and quarterly report in the SEC record with the published financial measures it tagged, 31 filings, each linked to its SEC index.

Filing record ends 2019-05-07

The latest filing in this captured record is a 10-Q filed 2019-05-07. No later filing is in the SEC companyfacts record captured on 2026-09-22. ARRAY BIOPHARMA INC may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2019-05-07fiscal Q3 2019401100001100412-19-000021
10-Q2019-02-05fiscal Q2 2019381070001100412-19-000005
10-Q2018-10-30fiscal Q1 201938790001100412-18-000037
10-K2018-08-14fiscal FY 2018411710001100412-18-000026
10-Q2018-05-09fiscal Q3 2018371050001100412-18-000007
10-Q2018-02-06fiscal Q2 2018371050001100412-18-000003
10-Q2017-10-31fiscal Q1 201837770001100412-17-000009
10-K2017-08-11fiscal FY 2017391670001628280-17-008555
10-Q2017-05-10fiscal Q3 2017371070001100412-17-000006
10-Q2017-02-09fiscal Q2 2017341010001100412-17-000003
10-Q2016-11-03fiscal Q1 201735750001100412-16-000054
10-K2016-08-19fiscal FY 2016391670001100412-16-000048
10-Q2016-05-04fiscal Q3 2016351000001100412-16-000045
10-Q2016-02-05fiscal Q2 2016351000001100412-16-000042
10-Q2015-11-06fiscal Q1 201634730001100412-15-000040
10-K2015-08-21fiscal FY 2015401530001100412-15-000023
10-Q2015-05-07fiscal Q3 2015351030001100412-15-000018
10-Q2015-02-04fiscal Q2 201531870001100412-15-000008
10-Q2014-11-05fiscal Q1 201530650001100412-14-000065
10-K2014-08-15fiscal FY 2014341200001100412-14-000048
10-Q2014-05-09fiscal Q3 201431870001100412-14-000026
10-Q2014-02-05fiscal Q2 201431870001100412-14-000010
10-Q2013-11-01fiscal Q1 201431670001100412-13-000033
10-K2013-08-12fiscal FY 2013341200001100412-13-000025
10-Q2013-05-07fiscal Q3 201331860001100412-13-000007
10-Q2013-02-06fiscal Q2 201331850001100412-13-000003
10-Q2012-10-30fiscal Q1 201328600001104659-12-072188
10-K2012-08-16fiscal FY 2012321130001047469-12-008381
10-Q2012-05-03fiscal Q3 201229820001104659-12-032437
10-Q2012-02-02fiscal Q2 201229810001104659-12-005933
10-Q/A2011-11-03fiscal Q1 201229590001104659-11-060651

Inspect the source

Entity
ARRAY BIOPHARMA INC / CIK 0001100412
Captured
SEC response SHA-256
d6de7aba2f580d837c96b6c945126994c3e912c8036958c5a7131ebd9c80e632

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001100412.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))